Email Us
Journal of Organoid & Bioscience | Volume 2 Number 1 Live Now! Journal of Organoid & Bioscience | Volume 2 Number 1 Live Now!
International Society of Organoid Research (ISoOR) proudly announces the publication of Volume 2, Number 1 of its esteemed journal, Journal of Organoid & Bioscience.
2024 07 25
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference in Singapore last year.
2024 03 08
A New Frontier in Science: ISoOR Launches Journal of Organoid & Bioscience A New Frontier in Science: ISoOR Launches Journal of Organoid & Bioscience
The International Society of Organoid Research (ISoOR) recently marked a significant advancement in the organoid field with the introduction of its new publication: Journal of Organoid & Bioscience (JOBs).
2023 12 29
Valo Health Bags $2.7bn AI Partnership with Novo Nordisk Valo Health Bags $2.7bn AI Partnership with Novo Nordisk
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
2023 09 26
Co-creating a New Era for Organoids: Successful Conclusion of the International Society of Organoid Research's First Annual Meeting Co-creating a New Era for Organoids: Successful Conclusion of the International Society of Organoid Research's First Annual Meeting
From August 7 to 8, 2023, the International Society of Organoid Research (ISoOR) held its inaugural annual meeting in Singapore. Hosted by ISoOR and co-organized by the Pharmacological Society (Singapore) and Scipolis, the conference was themed "Organoid: Accelerate Your Research."
2023 08 10
Organoids Making Their US Clinical Debut with CIDP Drug Organoids Making Their US Clinical Debut with CIDP Drug
The use of organoids in preclinical research has reached a tipping point, with U.S. FDA approval of the first drug to enter clinical trials on the basis of efficacy data derived only from these advanced cell models.
2022 12 15